Tolero
Showing 1 - 3 of 3
Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
- TP-0903
- TP-0903 and ibrutinib combination therapy
-
Phoenix, Arizona
- +5 more
Apr 4, 2022
Acute Myeloid Leukemia (AML) Trial in United States (Alvocidib (flavopiridol) and cytarabine (Ara-C), Alvocidib (flavopiridol))
Terminated
- Acute Myeloid Leukemia (AML)
- Alvocidib (flavopiridol) and cytarabine (Ara-C)
- Alvocidib (flavopiridol)
-
Clovis, California
- +17 more
Sep 22, 2022